Preclinical study points to cancer drugs as possible treatments for chronic nerve pain

Researchers astatine The University of Texas MD Anderson Cancer Center person recovered caller grounds that BRAF, a macromolecule commonly progressive successful cancer, plays a cardinal relation successful developing, amplifying and maintaining chronic symptom caused by nervus damage. BRAF inhibitors reduced symptom sensitivity successful preclinical models, suggesting the therapeutic imaginable of this attack for treating chronic nervus pain.